Medicare Enrolled
Dr. Chase Contino, M.D.
Cardiovascular Disease · Philadelphia, PA
Practice pattern: Remote & Electrophysiology
— Practice combining remote and electrophysiology services
Research-focused
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Contino from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Contino?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Contino
Dr. Chase Contino is a cardiovascular disease specialist in Philadelphia, PA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Contino performed 5,535 Medicare services across 3,093 unique beneficiaries.
Between the years covered by Open Payments, Dr. Contino received a total of $47,797 from 30 pharmaceutical and/or device companies across 219 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Contino is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 5% volume in PA
$47,797 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,535
Medicare services
Top 5% in PA for cardiovascular disease
3,093
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~395 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
726 | $33 | $110 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
570 | $20 | $80 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
545 | $21 | $65 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
458 | $24 | $125 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
412 | $96 | $180 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
353 | $64 | $122 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
323 | $11 | $45 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
294 | $7 | $30 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
199 | $107 | $268 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
190 | $21 | $60 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
156 | $41 | $80 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
150 | $141 | $361 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
119 | $30 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
89 | $144 | $275 |
| Electrocardiogram, 1-3 leads with physician review A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician. |
66 | $11 | $40 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
66 | $161 | $550 |
| Pacemaker insertion with heart chamber electrodes A surgical procedure to implant a pacemaker device and place electrodes into the upper and lower chambers of the heart to regulate heart rhythm. |
58 | $429 | $1,203 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
55 | $99 | $160 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
46 | $59 | $300 |
| New patient office visit, complex (60-74 min) | 40 | $168 | $380 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
39 | $86 | $250 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
39 | $14 | $60 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
39 | $2 | $25 |
| Heart catheterization to identify abnormal heart rhythm A tube is inserted into the heart chambers to record electrical activity and locate the source of an irregular heartbeat. |
38 | $226 | $650 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
37 | $20 | $90 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
37 | $708 | $1,600 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
34 | $161 | $485 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
34 | $1,376 | $2,800 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 34 | $626 | $1,600 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
30 | $115 | $305 |
| Permanent leadless pacemaker insertion A small, self-contained pacemaker is placed directly into the heart without using wires. The procedure is guided by imaging to ensure correct positioning. |
29 | $378 | $1,492 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
27 | $177 | $641 |
| Heart rhythm stimulator programming after drug infusion Adjustment of a heart rhythm stimulation device following a drug infusion. This procedure involves reprogramming the device settings to ensure proper function after the medication has been administered. |
25 | $70 | $800 |
| Insertion of implantable defibrillator system A surgical procedure to place an implantable cardioverter-defibrillator (ICD) device into the body. The device is connected to the heart to monitor heart rhythm and deliver shocks if dangerous arrhythmias occur. |
23 | $758 | $2,496 |
| Radiofrequency ablation for supraventricular tachycardia A procedure to locate and destroy abnormal heart tissue in the upper chambers of the heart that causes a rapid heart rate. |
23 | $694 | $1,961 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording, analyzing, and interpreting a continuous external electrocardiogram (EKG) over a period of more than 48 hours up to 7 days. |
22 | $224 | $750 |
| Insertion of implantable heart rhythm monitor A small device is placed under the skin to continuously record the heart's electrical activity. This helps detect irregular heart rhythms that may not appear during a standard office visit. |
21 | $3,889 | $7,500 |
| Removal of subcutaneous heart rhythm monitor This procedure involves the removal of a heart rhythm monitor that has been implanted under the skin. It is a minor surgical intervention to extract the device. |
18 | $50 | $302 |
| Insertion of left lower heart electrode for pacemaker or defibrillator A procedure to place an electrode in the lower part of the left side of the heart. This electrode is used to connect a pacemaker or defibrillator to help regulate the heart's rhythm. |
17 | $384 | $1,500 |
| Left heart catheterization with pacing and arrhythmia induction A procedure where catheters are inserted to record electrical activity and pace the left lower chamber of the heart. It also involves intentionally inducing an abnormal heart rhythm for diagnostic purposes. |
15 | $140 | $850 |
| Atrial fibrillation ablation with pulmonary vein isolation A procedure to treat atrial fibrillation by mapping the heart's electrical activity and destroying tissue causing irregular contractions. This is done by isolating the pulmonary veins using catheter-based destruction. |
15 | $787 | $2,850 |
| Removal and replacement of dual lead permanent pacemaker This procedure involves removing an existing permanent pacemaker with two leads and replacing it with a new device. It is performed to update or repair the heart rhythm management system. |
12 | $297 | $850 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
12 | $387 | $1,000 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
27.2% high complexity
5.9% medium
66.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$47,797
Total received (2018-2024)
Avg $6,828/year across 7 years
Top 10% in PA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
219
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Scientific / Research
Research funding and grants
$37,268 (78.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,530 (22.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,830
2023
$945
2022
$1,158
2021
$779
2020
$9,278
2019
$14,735
2018
$18,072
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$1,663
Philips North America LLC
$629
Medtronic, Inc.
$217
CVRx, Inc.
$80
SCPHARMACEUTICALS INC.
$70
Novartis Pharmaceuticals Corporation
$67
ABIOMED
$42
Janssen Pharmaceuticals, Inc
$17
Amgen Inc.
$17
SANOFI-AVENTIS U.S. LLC
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Top 3 companies account for 88.7% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic Vascular, Inc.
$23,077
Boston Scientific Corporation
$9,365
BOSTON SCIENTIFIC CORPORATION
$5,338
Medical Device Business Services, Inc.
$3,077
Abbott Laboratories
$2,858
Medtronic, Inc.
$713
Philips North America LLC
$629
Cook Medical LLC
$568
Novartis Pharmaceuticals Corporation
$307
Biosense Webster, Inc.
$261
CVRx, Inc.
$225
Janssen Pharmaceuticals, Inc
$183
Boehringer Ingelheim Pharmaceuticals, Inc.
$121
Amgen Inc.
$115
BIOTRONIK INC.
$102
Philips Electronics North America Corporation
$102
E.R. Squibb & Sons, L.L.C.
$98
Merck Sharp & Dohme LLC
$95
AstraZeneca Pharmaceuticals LP
$78
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$71
SCPHARMACEUTICALS INC.
$70
PFIZER INC.
$63
SANOFI-AVENTIS U.S. LLC
$62
ABIOMED
$59
Amarin Pharma Inc.
$58
CARDIVA MEDICAL, INC.
$32
Novo Nordisk Inc
$29
Lantheus Medical Imaging, Inc.
$13
AngioDynamics, Inc.
$13
Daiichi Sankyo Inc.
$13
Top 3 companies account for 79.0% of all-time payments
Associated products mentioned in payments ›
(9124) LM Undivided · (9278) Bridge · (9520) IGT Devices Undivided · ACCOLADE · ASSURITY · AVEIR · Advisor Catheter · AngioVac · Azure · Barostim Neo System · CAMZYOS · COBALT DR MRI SURESCAN · CONFIRM RX · COOK MEDICAL LEAD MANAGEMENT - LEAD EXTRACTION · CardioMEMS HF System · Cardiva VASCADE MVP VVCS 6-12F · CareLink · Carto 3 System · Confidense · Confirm Rx · Corlanor · Definity · ELIQUIS · EMBLEM · EMBLEM S ICD ELECTRODE DELIVERY SYSTEM · EMBLEM SICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · Ensite Cardiac Mapping System · FARXIGA · FUROSCIX · GALLANT · GENERAL THERAPIES · GENERAL - BRADY · GENERAL - THERAPIES · GENERAL BRADY · GENERAL THERAPIES · INGEVITY · INJECTAFER · Impella · JARDIANCE · JOT DX · LEQVIO · LUX-DX · LYNPARZA · LifeVest · MICRA · MULTAQ · Micra · OCTARAY MAPPING CATHETER · Ozempic · PRADAXA · QUADRA ASSURA · Quadra Assura CRT Defibrillator · RESONATE · Repatha · VERQUVO · Vascepa · Vascular Closure Device · ViewFlex Xtra ICE Catheter · WATCHMAN Access System · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (78%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work. Total industry engagement is in the top 10% for cardiovascular disease in PA.
Geographic Context
Cardiologists within 10 mi
744
Per 100K population
47.0
County median income
$60,698
Nearest hospital
THOMAS JEFFERSON UNIVERSITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Contino is a remote & electrophysiology specialist, with above-average Medicare volume (top 5% in PA), with research-focused industry engagement in the top 10% of PA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Contino experienced with remote monitoring of implantable heart rhythm device?
Based on Medicare claims data, Dr. Contino performed 726 remote monitoring of implantable heart rhythm device services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Contino receive payments from pharmaceutical companies?
Yes. Dr. Contino received a total of $47,797 from 30 companies across 219 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Contino's costs compare to other cardiologists in Philadelphia?
Dr. Contino's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Contino) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Philadelphia
Browse cardiologists in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology